«Markers for COVID-19 disease progression:
Comprehensive LC-MS characterization of the
metabolome with the Xevo G3 QTof»

Monday, 14 November16:00
(Greek Time)



Watch Professor Clare Mills from the University of Manchester discuss how LC/MS
metabolomic techniques are used to profile serum from COVID-19 inpatients using
our latest analytical workhorse, the Xevo G3 QTof.
We will also discuss how updates to the core technology improve workflows.

Presented by:

Clare Mills
University of Manchester

Prof Mills is Professor of molecular allergology at the University of Manchester. 
Her research is focused on applying molecular science to understand,
better diagnose and treat food allergies.

Learning Objectives:

- Discover how new Xevo G3 QTof provides comprehensive characterization of analytes
- Develop understanding of LC/MS and its use in metabolomic and lipidomic studies
- Delve into the world of omics, identifying statistically relevant markers for
disease and the impact on patients

Who should attend:

Scientists striving for improved instrument performance and ultimate
confidence in their analytical workflows.



Marketing Department


Sign up to Hellamco's Mailing List and check out our latest news.
HELLAMCO S.A. will process your personal data only for communication and updating purposes, will not distribute them on to third parties and will keep them in the database for 30 days. For more information regarding the processing of personal data and rights, please visit our relative privacy policy.